Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Combination group
Hospital Authority, Hong Kong
Cardiac Arrest
1 trial -
Combination of chemotherapy and immunotherapy
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
Peking University Third Hospital
Prostate Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Conservative treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Pancreatitis
1 trial -
Contrast-enhanced ultrasound-guided core biopsy
The First People's Hospital of Lianyungang
Pancreatic Disease
1 trial -
Control lidocaine cream
The First People's Hospital of Lianyungang
Atopic Dermatitis
1 trial -
Controlled low central venous pressure (CLCVP) technology
The First People's Hospital of Lianyungang
Acute Kidney Injury
1 trial -
Conventional second-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Copd Exacerbation Acute
1 trial -
Cordyceps cicadae
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visual Acuity
2 trials -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Primary Prevention Strategy
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Statin
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial -
Corticosteroid
Beijing Anzhen Hospital
Heart Valve Diseases
1 trial -
Corticosteroid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Valve Diseases
1 trial -
Cow's milk
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Infection
1 trial -
Crystalloid
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Cy-TB test
International Peace Maternity and Child Health Hospital
Latent Tuberculosis
1 trial -
Cyclosporin A
The First People's Hospital of Lianyungang
Acute Leukemia
1 trial -
DC-TC+GM-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Hepatocellular Carcinoma
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources